ALPRE.PA PAR
Predilife S.A.
1W: -10.4%
1M: -18.4%
3M: -56.5%
YTD: -71.4%
1Y: -71.9%
3Y: -84.0%
5Y: -86.3%
€0.91 ($1.02)
-0.00 (-0.44%)
Weekly Expected Move ±10.9%
€1
€1
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap€3.6M ($4.0M)
52W Range0.9-4
Volume2,344
Avg Volume749
Beta0.24
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOStephane Ragusa
Employees21
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2018-12-21
Websitepredilife.com
39, Rue Camille Desmoulins
Villejuif, IF 94805
FR
Villejuif, IF 94805
FR
33 9 53 75 85 43
About Predilife S.A.
Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare solutions and comprehensive breast screening tests. Among its notable products are MammoRisk, a diagnostic tool designed to forecast an individual's risk of developing breast cancer; DenSeeMammo, software for evaluating breast tissue density; and a specialized medical device developed for predicting prostate cancer risk.
Latest News
No recent news
Recent Insider Trades
No insider trades found